MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 140.9
(0.61%)
EUR 140.9
(0.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.6 Billion EUR | -9.63% |
| 2022 | 4.47 Billion EUR | 7.06% |
| 2021 | 4.17 Billion EUR | 40.0% |
| 2020 | 2.98 Billion EUR | 40.8% |
| 2019 | 2.12 Billion EUR | 22.76% |
| 2018 | 1.72 Billion EUR | -31.6% |
| 2017 | 2.52 Billion EUR | 1.77% |
| 2016 | 2.48 Billion EUR | 34.6% |
| 2015 | 1.84 Billion EUR | 4.61% |
| 2014 | 1.76 Billion EUR | 9.39% |
| 2013 | 1.61 Billion EUR | 67.16% |
| 2012 | 963.6 Million EUR | -2.18% |
| 2011 | 985.1 Million EUR | -11.2% |
| 2010 | 1.1 Billion EUR | 78.68% |
| 2009 | 620.9 Million EUR | -15.11% |
| 2008 | 731.4 Million EUR | -25.04% |
| 2007 | 975.7 Million EUR | -11.75% |
| 2006 | 1.1 Billion EUR | 15.7% |
| 2005 | 955.6 Million EUR | -8.42% |
| 2004 | 1.04 Billion EUR | 80.13% |
| 2003 | 579.3 Million EUR | 17.08% |
| 2002 | 494.8 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.15 Billion EUR | -26.26% |
| 2024 Q1 | 1.07 Billion EUR | 29.4% |
| 2023 Q1 | 1.03 Billion EUR | 16.42% |
| 2023 Q2 | 969 Million EUR | -6.38% |
| 2023 FY | 4.04 Billion EUR | -9.63% |
| 2023 Q4 | 830 Million EUR | -15.56% |
| 2023 Q3 | 983 Million EUR | 1.44% |
| 2022 FY | 4.47 Billion EUR | 7.06% |
| 2022 Q1 | 1.17 Billion EUR | 12.9% |
| 2022 Q2 | 1.17 Billion EUR | 0.34% |
| 2022 Q4 | 889 Million EUR | -27.96% |
| 2022 Q3 | 1.23 Billion EUR | 4.84% |
| 2021 Q3 | 1.04 Billion EUR | -0.19% |
| 2021 Q4 | 1.03 Billion EUR | -0.76% |
| 2021 FY | 4.17 Billion EUR | 40.0% |
| 2021 Q1 | 1.04 Billion EUR | 70.7% |
| 2021 Q2 | 1.04 Billion EUR | 0.58% |
| 2020 FY | 2.98 Billion EUR | 40.8% |
| 2020 Q1 | 716 Million EUR | 39.03% |
| 2020 Q2 | 491 Million EUR | -31.42% |
| 2020 Q3 | 1.16 Billion EUR | 137.68% |
| 2020 Q4 | 611 Million EUR | -47.64% |
| 2019 Q4 | 515 Million EUR | -15.3% |
| 2019 Q1 | 379 Million EUR | 11.14% |
| 2019 Q2 | 618 Million EUR | 63.06% |
| 2019 Q3 | 608 Million EUR | -1.62% |
| 2019 FY | 2.12 Billion EUR | 22.76% |
| 2018 Q4 | 341 Million EUR | -30.55% |
| 2018 Q2 | 392 Million EUR | -24.32% |
| 2018 Q1 | 518 Million EUR | 114.05% |
| 2018 FY | 1.72 Billion EUR | -31.6% |
| 2018 Q3 | 491 Million EUR | 25.26% |
| 2017 Q3 | 901 Million EUR | 43.47% |
| 2017 Q2 | 628 Million EUR | -16.82% |
| 2017 Q1 | 755 Million EUR | 85.96% |
| 2017 FY | 2.52 Billion EUR | 1.77% |
| 2017 Q4 | 242 Million EUR | -73.14% |
| 2016 Q1 | 849 Million EUR | 184.8% |
| 2016 Q4 | 406 Million EUR | -39.94% |
| 2016 Q3 | 676 Million EUR | 22.91% |
| 2016 Q2 | 550 Million EUR | -35.22% |
| 2016 FY | 2.48 Billion EUR | 34.6% |
| 2015 Q2 | 501.4 Million EUR | 4.46% |
| 2015 FY | 1.84 Billion EUR | 4.61% |
| 2015 Q4 | 298.1 Million EUR | -47.13% |
| 2015 Q3 | 563.8 Million EUR | 12.45% |
| 2015 Q1 | 480 Million EUR | 13.26% |
| 2014 Q4 | 423.8 Million EUR | -1.19% |
| 2014 FY | 1.76 Billion EUR | 9.39% |
| 2014 Q1 | 468.3 Million EUR | 77.25% |
| 2014 Q2 | 441 Million EUR | -5.83% |
| 2014 Q3 | 428.9 Million EUR | -2.74% |
| 2013 Q2 | 465.4 Million EUR | 16.52% |
| 2013 FY | 1.61 Billion EUR | 67.16% |
| 2013 Q4 | 264.2 Million EUR | -45.16% |
| 2013 Q3 | 481.8 Million EUR | 3.52% |
| 2013 Q1 | 399.4 Million EUR | 28.14% |
| 2012 FY | 963.6 Million EUR | -2.18% |
| 2012 Q1 | 311.2 Million EUR | 6.68% |
| 2012 Q2 | 23.2 Million EUR | -92.54% |
| 2012 Q4 | 311.7 Million EUR | -2.01% |
| 2012 Q3 | 318.1 Million EUR | 1271.12% |
| 2011 Q2 | -22.5 Million EUR | -104.25% |
| 2011 Q3 | 333.3 Million EUR | 1581.33% |
| 2011 Q4 | 291.7 Million EUR | -12.48% |
| 2011 FY | 985.1 Million EUR | -11.2% |
| 2011 Q1 | 529.5 Million EUR | 319.57% |
| 2010 Q4 | 126.2 Million EUR | -65.28% |
| 2010 FY | 1.1 Billion EUR | 78.68% |
| 2010 Q3 | 363.5 Million EUR | 11.85% |
| 2010 Q1 | 294.8 Million EUR | 247.23% |
| 2010 Q2 | 325 Million EUR | 10.24% |
| 2009 Q1 | 129.3 Million EUR | 0.0% |
| 2009 Q2 | 184.5 Million EUR | 42.69% |
| 2009 FY | 620.9 Million EUR | -15.11% |
| 2009 Q3 | 222.2 Million EUR | 20.43% |
| 2009 Q4 | 84.9 Million EUR | -61.79% |
| 2008 FY | 731.4 Million EUR | -25.04% |
| 2007 FY | 975.7 Million EUR | -11.75% |
| 2006 FY | 1.1 Billion EUR | 15.7% |
| 2005 FY | 955.6 Million EUR | -8.42% |
| 2004 FY | 1.04 Billion EUR | 80.13% |
| 2003 FY | 579.3 Million EUR | 17.08% |
| 2002 FY | 494.8 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| MPH Health Care AG | 15.7 Million EUR | -22887.261% |
| Apontis Pharma AG | -15.1 Million EUR | 24000.662% |
| Dermapharm Holding SE | 182.89 Million EUR | -1873.274% |
| Evotec SE | -47.5 Million EUR | 7696.775% |
| PharmaSGP Holding SE | 40.91 Million EUR | -8720.941% |
| SynBiotic SE | -7.58 Million EUR | 47699.867% |